Clinical trial
Inflammation as a Predictor in Cardioversion of Atrial Fibrillation
NCT00590525 is registered in ClinicalTrials.gov with Creighton University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inflammation as a Predictor in Cardioversion of Atrial Fibrillation
- Lead sponsor
- Creighton University
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- June 30, 2009
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.